Back to Authors

Del Mastro, Lucia

0000-0002-9546-5841

Mayo Clinic

Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy.

Citations 2

Pregnancy After Breast Cancer: A Systematic Review and Meta-Analysis
Lambertini, Matteo , Blondeaux, Eva , Bruzzone, Marco , Perachino, Marta , Anderson, Richard A. , Azambuja, Evandro de , Poorvu, Philip D. , Kim, Hee Jeong , Villarreal‐Garza, Cynthia , Pistilli, Barbara , Vaz-Luís, Inês , Saura, Cristina , Ruddy, Kathryn J. , Franzoi, Maria Alice , Sertoli, Chiara, Azim, Hatem A. , Demeestere, Isabelle , Mastro, Lucia Del , Pagani, Olivia , de Azambuja, Evandro , Ceppi, Marcello , Azim, Hatem A , Amant, Frederic , Demeestere, Isabelle , Del Mastro, Lucia , Partridge, Ann H , Peccatori, Fedro A , Lambertini, Matteo , Saura, Cristina , Villarreal-Garza, Cynthia , Bruzzone, Marco , Amant, Frédéric , Partridge, Ann H.

Journal of Clinical Oncology | July 1, 2021 | Volume: 39 | Issue: 29 | Pages: 3293-3305

10.1200/jco.21.00535 Get It

PURPOSE Many patients and physicians remain concerned about the potential detrimental effects of pregnancy after breast cancer (BC) in terms of reproductive outcomes and maternal safety. This systematic review and meta-analysis aimed at providing updated evidence on these topics. METHODS A systematic literature review was conducted to identify studies including patients with a pregnancy after BC (PROSPERO number CRD42020158324). Likelihood of pregnancy after BC, their reproductive outcomes, and maternal safety were assessed. Pooled relative risks, odds ratios (ORs), and hazard ratios (HRs) with 95% CIs were calculated using random effects models. RESULTS Of 6,462 identified records, 39 were included involving 8,093,401 women from the general population and 112,840 patients with BC of whom 7,505 had a pregnancy after diagnosis. BC survivors were significantly less likely to have a subsequent pregnancy compared with the general population (relative risk, 0.40; 95% CI, 0.32 to 0.49). Risks of caesarean section (OR, 1.14; 95% CI, 1.04 to 1.25), low birth weight (OR, 1.50; 95% CI, 1.31 to 1.73), preterm birth (OR, 1.45; 95% CI, 1.11 to 1.88), and small for gestational age (OR, 1.16; 95% CI, 1.01 to 1.33) were significantly higher in BC survivors, particularly in those with previous chemotherapy exposure, compared with the general population. No significantly increased risk of congenital abnormalities or other reproductive complications were observed. Compared to patients with BC without subsequent pregnancy, those with a pregnancy had better disease-free survival (HR, 0.66; 95% CI, 0.49 to 0.89) and overall survival (HR, 0.56; 95% CI, 0.45 to 0.68). Similar results were observed after correcting for potential confounders and irrespective of patient, tumor, and treatment characteristics, pregnancy outcome, and timing of pregnancy. CONCLUSION These results provide reassuring evidence on the safety of conceiving in BC survivors. Patients' pregnancy desire should be considered a crucial component of their survivorship care plan.
Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients
Lambertini, Matteo , Campbell, Christine , Korde, Larissa A. , Izquierdo, Miguel , Fumagalli, Debora , Mastro, Lucia Del , Jackisch, Christian , Láng, István, Boyle, Frances , Barrios, Carlos H. , Baselga, José, Moreno‐Aspitia, Alvaro , Piccart, Martine , Gelber, Richard D. , Azambuja, Evandro de , Lambertini, Matteo , de Azambuja, Evandro , Del Mastro, Lucia , Bines, José , Ignatiadis, Michail , Pritchard, Kathleen I. , Wolff, Antonio C. , Untch, Michael , Smith, Ian , Xu, Binghe

JNCI: Journal of the National Cancer Institute | April 18, 2018 | Volume: 111 | Issue: 1 | Pages: 86-94

10.1093/jnci/djy094 Get It